Avicannaâ or the â
Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that Avicannaâs Chief Executive Officer, Aras Azadian has been invited to present at
Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC. The conference will take place on March 17 and 18 from 9:00 am-5:00 pm EST featuring roundtable discussions with C-suite executives moderated by Maxim Research Analysts, fireside chats with live Q&A, and presentations from hundreds of issuers both domestically and internationally.
During this virtual conference, Avicanna will present along with other important voices in the cannabis industry. You will also hear from healthcare leaders treating a broad range of indications; cannabis entrepreneurs exploring the changing landscape; tech innovators changing how we work and pl
Avicanna to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
(AVCNF), (RWBYF) - Canadian Bio-Pharmaceutical Avicanna is Leading in 2021
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Demand for Medical Kits and Trays to Soar and More News
packagingdigest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from packagingdigest.com Daily Mail and Mail on Sunday newspapers.
Author of the article:
GlobeNewswire
Publishing date: Jan 28, 2021  â¢Â January 28, 2021  â¢Â 7 minute read  â¢Â
Article content
RHO Phyto Deep Tissue Gels will be initially available on the Medical Cannabis by Shoppers Drug Mart⢠online platform and expanded into specific consumer retail channels in February 2021.
Initiation of osteoarthritis preclinical trials in Canada in addition to the enrollment of the products into the UHN MC-RWE study to evaluate the effectiveness on pain, sleep, anxiety, and depression.
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) â Avicanna Inc. (â
Avicannaâ or the â
Companyâ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the launch of the RHO Phyto⢠Deep Tissue Gels (the â